CME CirclePrint this Activity for Offline ReferenceInstructions on Taking Medscape CME

Advancing the Art and Science of Treating RA and Spondyloarthropathies: The Expanding Role of TNF Inhibitors CME
Chairperson: Edward C. Keystone, MD; Faculty: John C. Davis, Jr, MD, MPH, MS; Mark C. Genovese, MD; Christopher T. Ritchlin, MD
Disclosures

Release Date: February 28, 2003; Valid for credit through February 28, 2004

This activity has expired.
CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.


This CME activity is based on transcripts and slides of presentations as delivered by the faculty at the "Advancing the Art and Science of Treating RA and Spondyloarthropathies: The Expanding Role of TNF Inhibitors" satellite symposium to the American College of Rheumatology 66th Annual Scientific Meeting held in New Orleans, Louisiana on October 27, 2002.

Note: Participants in attendance at the ACR Satellite Symposium titled "Advancing the Art and Science of Treating RA and Spondyloarthropathies: The Expanding Role of TNF Inhibitors" held in New Orleans on Sunday, October 27, 2002, are NOT eligible for credit for participation in this enduring material.

Contents of This CME Activity
  1. Evaluating the Expanding Body of Evidence in the Context of Current Approaches to RA
    Learning More in the Treatment of Rheumatoid Arthritis
    Monotherapy With Biologics
    Add-On Therapy With Biologics
    Combination Biologic Therapy
    Aggressive and Early Intervention in Rheumatoid Arthritis
    Use of Etanercept in Early Rheumatoid Arthritis
    Rheumatoid Arthritis and Radiographic Destruction
    Radiographic Outcomes With Biologic Therapy
    The Practicalities in Rheumatoid Arthritis
    Conclusions

  2. Advances in the Treatment of Psoriatic Arthritis: Effects of TNF Inhibitors
    Psoriatic Arthritis: Overview
    Clinical Features of Psoriatic Arthritis
    Cytokines and Inflammation in Psoriatic Arthritis
    Etanercept in Psoriatic Arthritis: Phase 2 and 3 Studies
    Etanercept in Psoriatic Arthritis: Phase 2
    Psoriatic Arthritis: Bone Resorption
    Osteoclastogenesis and Tumor Necrosis Factor
    Effects of Etanercept on Radiographic Progression in Psoriatic Arthritis: Study Background
    Effects of Etanercept on Radiographic Progression in Psoriatic Arthritis: Study Findings
    Psoriatic Arthritis: New Bone Formation
    Use of Infliximab in Psoriatic Arthritis
    Use of Leflunomide in Psoriatic Arthritis
    Conclusions

  3. The Changing Landscape of Ankylosing Spondylitis: The Emerging Role of TNF Inhibitors
    The Spondyloarthropathies
    Ankylosing Spondylitis
    Extra-Articular Manifestations of Ankylosing Spondylitis
    Current and Future Treatment Options for Ankylosing Spondylitis
    The Rationale for Use of Tumor Necrosis Factor Inhibition in Ankylosing Spondylitis
    Use of Etanercept in Ankylosing Spondylitis
    Use of Etanercept in Ankylosing Spondylitis: Study Background
    Use of Etanercept in Ankylosing Spondylitis: Study Findings
    Use of Etanercept in Ankylosing Spondylitis: Quality of Life and Adverse Effects
    Another Study of Etanercept in Ankylosing Spondylitis
    Use of Infliximab in Ankylosing Spondylitis
    Conclusions

  4. TNF Inhibition: Where Do We Go From Here?
    Use of Tumor Necrosis Factor (TNF) Inhibition for Rheumatic and Nonrheumatic Diseases
    New Approaches to Tumor Necrosis Factor Inhibition
    Additional Approaches to Tumor Necrosis Factor Inhibition

These educational activities, certified by accredited providers, were not prepared by Medscape's editors, but are made available on our site as a service to our audience. Authors are routinely instructed by the provider to disclose significant financial relationships and mention of investigational drugs and unapproved indications. Medscape has received a fee for posting these activities. Direct questions or comments to: CME@webmd.net.

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape, Discovery International, the companies providing educational grants or the authors and writers. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. All readers and continuing education participants should verify all information and consult a qualified healthcare professional before treating patients or utilizing any therapeutic product discussed in this educational activity.

 
Copyright © 2003 Discovery International.
Amgen, Wyeth
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME Information
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.